Location: New York, NY
CIK: 0001952142 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $401M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,872,601 | $37.98M | 9.5% | $17.25 | -0.8% | COM | 87164F105 |
| ROIV | ROIVANT SCIENCES LTD | 2,712,778 | $32.09M | 8.0% | $10.18 | +16.2% | SHS | G76279101 |
| IMVT | IMMUNOVANT INC | 1,118,508 | $27.71M | 6.9% | $31.46 | -9.8% | COM | 45258J102 |
| — | MERUS N V | 614,812 | $25.85M | 6.5% | $39.75 | — | COM | N5749R100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 317,060 | $16.21M | 4.0% | $42.31 | +32.2% | COM | 22663K107 |
| XENE | XENON PHARMACEUTICALS INC | 375,845 | $14.73M | 3.7% | $41.35 | 0.0% | COM | 98420N105 |
| INCY | INCYTE CORP | 193,623 | $13.37M | 3.3% | $66.25 | +7.6% | COM | 45337C102 |
| ALKS | ALKERMES PLC | 416,968 | $11.99M | 3.0% | $28.50 | +0.9% | SHS | G01767105 |
| DNLI | DENALI THERAPEUTICS INC | 584,328 | $11.91M | 3.0% | $22.81 | +12.2% | COM | 24823R105 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 208,016 | $11.64M | 2.9% | $53.78 | +2.7% | COM | 76243J105 |
| NUVL | NUVALENT INC | 145,234 | $11.37M | 2.8% | $93.39 | 0.0% | COM | 670703107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 641,964 | $10.75M | 2.7% | $16.65 | — | SPONSORED ADS | 152309100 |
| PRAX | PRAXIS PRECISION MEDICINES I | 134,178 | $10.33M | 2.6% | $52.51 | +37.8% | COM NEW | 74006W207 |
| BMY | BRISTOL-MYERS SQUIBB CO | 166,068 | $9.393M | 2.3% | $43.65 | +20.5% | COM | 110122108 |
| WVE | WAVE LIFE SCIENCES LTD | 721,209 | $8.921M | 2.2% | $10.28 | +29.8% | SHS | Y95308105 |
| RVMD | REVOLUTION MEDICINES INC | 193,535 | $8.465M | 2.1% | $49.87 | +1.2% | COM | 76155X100 |
| KALV | KALVISTA PHARMACEUTICALS INC | 992,803 | $8.409M | 2.1% | $10.36 | 0.0% | COM | 483497103 |
| JANX | JANUX THERAPEUTICS INC | 145,876 | $7.81M | 1.9% | $42.35 | +24.9% | COM | 47103J105 |
| INSM | INSMED INC | 106,610 | $7.36M | 1.8% | $72.02 | 0.0% | COM PAR $.01 | 457669307 |
| SRRK | SCHOLAR ROCK HLDG CORP | 166,307 | $7.188M | 1.8% | $32.56 | 0.0% | COM | 80706P103 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 949,401 | $7.026M | 1.8% | $9.27 | 0.0% | COM | 462260100 |
| BNTX | BIONTECH SE | 61,403 | $6.997M | 1.7% | $113.95 | — | SPONSORED ADS | 09075V102 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 500,966 | $6.978M | 1.7% | $5.99 | +83.0% | COM | 03969K108 |
| BHVN | BIOHAVEN LTD | 186,413 | $6.963M | 1.7% | $36.52 | +27.8% | COM | G1110E107 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,328,492 | $5.947M | 1.5% | $3.61 | -22.0% | COM | 92840H400 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 141,714 | $5.47M | 1.4% | $43.60 | 0.0% | COM | 74366E102 |
| — | ACELYRIN INC | 1,704,825 | $5.353M | 1.3% | $4.52 | — | COM | 00445A100 |
| SRZN | SURROZEN INC | 350,573 | $5.031M | 1.3% | $10.29 | +3.1% | COM NEW | 86889P208 |
| MLYS | MINERALYS THERAPEUTICS INC | 400,101 | $4.925M | 1.2% | $13.08 | 0.0% | COM | 603170101 |
| NMRA | NEUMORA THERAPEUTICS INC. | 428,137 | $4.538M | 1.1% | $11.98 | 0.0% | COM | 640979100 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 579,500 | $4.317M | 1.1% | $9.31 | 0.0% | COM NEW | 30233G209 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 101,809 | $4.283M | 1.1% | $49.61 | 0.0% | COM | 90400D108 |
| — | 89BIO INC | 545,800 | $4.268M | 1.1% | $7.82 | — | COM | 282559103 |
| CYTK | CYTOKINETICS INC | 83,576 | $3.931M | 1.0% | $52.59 | -1.3% | COM NEW | 23282W605 |
| CTNM | CONTINEUM THERAPEUTICS INC | 265,833 | $3.894M | 1.0% | $15.84 | 0.0% | CL A | 21217B100 |
| EWTX | EDGEWISE THERAPEUTICS INC | 132,706 | $3.543M | 0.9% | $29.68 | +7.3% | COM | 28036F105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 270,983 | $3.406M | 0.9% | $15.05 | 0.0% | COM | 77313F106 |
| JSPR | JASPER THERAPEUTICS INC | 135,244 | $2.892M | 0.7% | $20.82 | 0.0% | COM NEW | 471871202 |
| — | TOURMALINE BIO INC | 126,400 | $2.563M | 0.6% | $22.67 | — | COM | 89157D105 |
| ELVN | ENLIVEN THERAPEUTICS INC | 96,716 | $2.176M | 0.5% | $25.92 | 0.0% | COM | 29337E102 |
| BBOT | HELIX ACQUISITION CORP II | 200,900 | $2.109M | 0.5% | $10.35 | +1.5% | CL A ORD SHS | G4444H101 |
| TARA | PROTARA THERAPEUTICS INC | 332,394 | $1.755M | 0.4% | $2.98 | +8.6% | COM STK | 74365U107 |
| QURE | UNIQURE NV | 90,000 | $1.589M | 0.4% | $8.63 | 0.0% | SHS | N90064101 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 150,000 | $1.527M | 0.4% | $10.07 | +0.3% | CL A ORD SHS | G70077105 |
| — | VERONA PHARMA PLC | 28,136 | $1.307M | 0.3% | $46.44 | — | SPONSORED ADS | 925050106 |
| — | CIDARA THERAPEUTICS INC | 47,642 | $1.281M | 0.3% | $26.88 | — | COM NEW | 171757206 |
| ATYR | ATYR PHARMA INC | 200,475 | $726K | 0.2% | $3.03 | 0.0% | COM NEW | 002120202 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1,575,000 | $581K | 0.1% | $5.99 | +83.0% | Call | 03969K108 |
| QQQ | INVESCO QQQ TR | 70,000 | $515K | 0.1% | — | — | Put | 46090E103 |
| TECX | TECTONIC THERAPEUTIC INC | 9,434 | $436K | 0.1% | $42.29 | 0.0% | COM | 878972108 |
| SPY | SPDR S&P 500 ETF TR | 85,000 | $414K | 0.1% | — | — | Put | 78462F103 |
| SRRK | SCHOLAR ROCK HLDG CORP | 100,000 | $228K | 0.1% | $32.56 | 0.0% | Call | 80706P103 |
| HIMS | HIMS & HERS HEALTH INC | 75,000 | $75,000 | 0.0% | — | — | Call | 433000106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 234,100 | $51,025 | 0.0% | $17.25 | -0.8% | Call | 87164F105 |